The creatinine that rose after GDMT: hemodynamic dip or structural decline?
Mr. R, 74, has HFrEF (EF 30%), type 2 diabetes, and CKD. Four weeks ago his creatinine was 2.0 mg/dL (eGFR 32) with potassium 4.6. Since then his cardiologist added sacubitril/valsartan and spironolactone, and he has been taking ibuprofen 600 mg three times daily for knee pain. Today creatinine is 2.9 mg/dL (eGFR 21), potassium 5.3 mmol/L, BP 98/62 (usual 130/78), weight up 3 kg, JVD at 45 degrees, bibasilar crackles, 2+ edema, and he reports lightheadedness on standing. Urine output is 900 mL/day. Bladder scan is 40 mL; he has no history of stones or obstruction.
1. Is this creatinine rise most consistent with a hemodynamic eGFR dip or with structural kidney injury? What in the case supports each possibility, and which single additional finding would most change your conclusion?
Read the worked answer
Reason it through rather than reacting to the number.
- Favoring hemodynamic (expected) dip: the rise began within weeks of starting an ARNI plus a mineralocorticoid receptor antagonist, both of which predictably lower intraglomerular pressure and raise creatinine; a rise of roughly 30% or less that stabilizes is commonly accepted as a trade-off for cardiac benefit. He is also on an NSAID, which blunts afferent vasodilation, and his BP has dropped with postural symptoms.
- Favoring structural injury: the NSAID plus volume shifts could produce true tubular injury; potassium 5.3 with an MRA is a red flag for worsening renal function; and 3 kg weight gain with JVD and crackles means he is congested despite a rising creatinine - a cardiorenal picture where "hold fluids" and "hold diuretics" are both wrong if done reflexively.
- Most decisive additional finding: a urinalysis with microscopy (and urine protein quantitation). New proteinuria, dysmorphic RBCs, or RBC casts point to glomerular/structural disease and change this from a dose-adjustment problem into a nephrology workup. A reassuring bland sediment with stable creatinine in 5–7 days supports the hemodynamic explanation. Bladder scan and history already make obstruction unlikely.
Do not treat the number in isolation - correlate it with volume status, potassium, and the medication timeline before recommending any change to his heart failure regimen.
2. List your next 24-hour actions in priority order and justify each. State explicitly what you would not do.
Read the worked answer
Priority actions (24 hours):
- Stop the ibuprofen and offer an alternative analgesic (e.g., acetaminophen within safe dosing). The NSAID is the most modifiable nephrotoxin and is antagonizing both his diuretic and his transplant-protective… i.e., kidney-protective therapy. Highest yield, lowest risk.
- Hold the spironolactone and notify the prescriber, because potassium 5.3 with an MRA plus declining eGFR is a hyperkalemia trajectory. Also review the diuretic dose - he is congested, so the answer is usually a calibrated diuretic adjustment, not stopping it.
- Assess volume and perfusion together: orthostatic vitals, daily weights, edema, lung sounds, and a symptom review. His lightheadedness argues against simply pushing more diuresis without examining him.
- Repeat BMP in 3–7 days, not months, and give him written parameters for calling sooner.
- Avoid further nephrotoxins - no contrast, no additional NSAIDs, review OTC and herbal products.
What I would not do: I would not stop the ARNI on the basis of this creatinine alone. A modest, stable rise after initiation is an anticipated effect, and discontinuing it removes a mortality benefit. That decision belongs to the prescriber, informed by trend data rather than one value. I would also not order a renal ultrasound in the absence of obstruction signs, and I would not restrict fluid in a patient who is clinically congested without a nephrology/cardiology plan.
3. Write the teaching plan you would use with Mr. R, including sick-day rules, and explain how you would confirm he can act on it.
Read the worked answer
Teach in small chunks with teach-back after each.
- Sick-day rules: if he has vomiting, diarrhea, fever, or cannot eat or drink normally, he should call the office before taking his next doses - medicines commonly held during acute illness include ACEi/ARB/ARNI, MRAs, diuretics, NSAIDs, metformin, and SGLT2 inhibitors. Framing: "these medicines protect your heart and kidneys when you are well; when you are dehydrated they can hurt them."
- NSAIDs: explain that ibuprofen, naproxen, and "arthritis" combination products all count, and that acetaminophen is his default unless told otherwise.
- What to report: weight gain of more than 2–3 lb in a day or 5 lb in a week, decreased urination, new swelling, dizziness on standing, muscle weakness or palpitations (hyperkalemia), and any potassium-containing salt substitute.
- Diet: review salt substitutes (potassium chloride) and high-potassium foods given his K 5.3.
Confirming action, not recall: ask him to demonstrate what he would do tonight if he developed vomiting, using his own pill bottles - he should identify which to hold and whom to call. Have him restate the weight threshold in his own words and show where he writes his daily weight. Document the teach-back result; if he cannot name the medicines to hold, repeat with a simplified picture list and involve a family member or pharmacist.